LLS Focuses on Molecular Drivers for Leukemia

Leukemia & Lymphoma Society Initiatives to Halt Early Stage Myeloid Blood Cancers Fourth in ASH 2014 Series by David Wallace PV Reporter sits down with Dr Lee Greenberger, Chief Scientific Officer with LLS, to discuss initiatives to halt early stage myeloid blood cancers (MPNs & MDS).   LLS has grants with Dana Farber to better understand […]

Leukemia & Lymphoma Society Launches New Program to Halt Progression of Myeloid Blood Cancers

The LLS and Janssen Research & Development, LLC  have committed $1.7 million for the initiative White Plains, NY (October 28, 2014) – The Leukemia & Lymphoma Society has initiated a program to fund research projects seeking to better understand and, ultimately, stop progression of certain types of blood cancers from early-stage malignancies to much more […]

error: Content is protected !